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Size Specific Trapping at a Convergent Stagnation Point
Sarah Jeanfavre, Jennifer Pearce.
Roger Williams University, Bristol, RI, USA.
DNA has been observed to be trapped at a convergent stagnation point
created by opposite rotating vortices in simulations based on the lattice-
Boltzmann method using a bead-spring model for the DNA. Previous work
has successfully separated polymers whose length differs by a factor of 2.
However more precise separation based on length could potentially be
achieved. Preliminary simulations have trapped 60% of the smaller strands
in polymers length ratio 1.5:1. Mastering this technique could allow advance-
ments in developing microfluidic techniques for DNA amplification based on
PCR and purification of the PCR product. Additionally these simulations
mimic conditions found in pores of hydrothermal vents, giving hypothesis
on the development of life.
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Alexey Aprelev1, William Stephenson1, Hongseok (Moses) Noh1,
Maureen Meier2, Frank A. Ferrone1.
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The pathology of sickle cell disease arises from the occlusion of small blood
vessels because of polymerization of the sickle hemoglobin within the red cells.
We present measurements using a novel microfluidic method to determine the
pressure required to eject individual red cells from a capillary-sized channel
after the cell has sickled. We find that the maximum pressure is only around
100 Pa, much smaller than typically found in the microcirculation. This ex-
plains why experiments using animal models have not observed occlusion
beginning in capillaries. The magnitude of the pressure and its dependence
on intracellular concentration are both well described as consequences of sickle
hemoglobin polymerization acting as a Brownian ratchet. Given the recently-
determined stiffness of sickle hemoglobin gels (Zakharov, Aprelev, Turner &
Ferrone, Biophys J, 99:1149-1156, 2010), the observed obstruction seen in
sickle cell disease as mediated by adherent cells can now be rationalized,
and surprisingly suggests a window of maximum vulnerability to occlusion
during the circulation of sickle cells.
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Engineering Myosin V Velocity by Tuning Nanocomposite Morphology
Matthew A. Caporizzo, Yale E. Goldman, Russell J. Composto.
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Devices which utilize biological components such as molecular motors may
be capable of detecting or separating analytes with speed and resolution
rivaling macroscopic instruments. The design and manufacturing of such
devices requires detailed understanding of self-assembly and interactions
of biological materials with synthetic environments. We demonstrated that
nano-scale roughness modulates surface binding of F-actin (Langmuir
28:12216; 2012). By controllably converting a thin film of polystyrene-
random-tert butyl acrylate copolymer to polyacrylic acid (PAA), we grafted
amine-functionalized nanoparticles at high coverage to the PAA hydrogel,
creating a surface with tunable roughness. Extending that approach here,
we explore the effect of nanocomposite morphology on myosin V processive
motility. We find that tuning the size and density of the surface grafted
nanoparticles controls the velocity and run length of myosin V. Velocity
decreases significantly as the nanoparticle size is increased independent
of the concentration of MgATP. This effect of particle size may be due to
changes in net charge, nanoparticle curvature at the interaction sites, or
tortuosity of the actin imposed by the surface features. Experiments to dis-
tinguish these hypotheses are underway. Further understanding of the rela-
tionship between nanoparticle surface morphology and activity of actin in
support of motility may permit the engineering of stops or stalls with high
spacial precision into biomolecular devices. Supported by NSF/NSEC grant
DMR08-32802.
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Ashleigh Steckly, Ming Li Tan, Laird Forrest, Prajnaparamita Dhar.
University of Kansas, Lawrence, KS, USA.
Increased manufacturing of engineered nanoparticles (ENPs) with commercial
and biomedical applications has led to an increase in the release of these
particles into the environment. Since the pulmonary route is an obvious one
for the intake of these nanoparticles, concerns regarding potential health risks
of these NPs has also seen a rapid increase in recent years.In this work, we describe the interaction of an engineered carbon nanoparticle
(nanodiamond ENDs) with a model lung surfactant system (DPPC) both as
a function of time of exposure and concentration. Using surface pressure vs.
area per molecule coupled with fluorescence microscopy, we study lipid/
END interactions for several weeks. Our results indicate that over short times
(0-2 days exposure) the ENDs do not sig-
nificantly affect the biophysical properties
of this model surfactant. However after
longer exposure, the ENDs begin to alter
the surface tension lowering ability and
domain morphology of DPPC. Our results
indicate that long term exposure to these
ENDs cause a lowering of line tension of
the film, in a manner similar to interac-
tions between DPPC and small (<2 wt
%) amounts of cholesterol.3481-Pos Board B636
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Lungs epithelium is the largest surface of the human body in contact with the
environment to provide the needed gas exchange for living. It is covered by
Pulmonary Surfactant (PS), which is a lipid-protein complex in charge of re-
ducing the surface tension at the air-liquid respiratory interface so minimizing
the work of breathing. Thereby, collapse is avoided. Likewise PS is responsible
for innate defense mechanisms preventing the entry of inhaled pathogenic
entities.
As a result of this lung specific design, the pulmonary route of administration is
acquiring a large projection in the design of new strategies in medicine. It offers
a great number of benefits in local treatment of lung diseases. In this context,
Gold Nanoparticles (GNPs) seem to be a promising tool. They might improve
current diagnostics and treatments due to their outstanding optical properties
and ease of tuning size and shape.
Since the PS layer is the first surface where NPs impinge, many studies are an-
alyzing the influence of NPs onto the biophysical properties of PS, which will
define their distribution and clearance. Therefore a deep understanding of NP-
PS interaction is required as a previous step to elucidate their impact on toxicity
and to develop the potential of PS as an efficient and selective vehicle of NPs.
The aim of this work is to analyze the size and coating effect of GNPs, on the
functional properties of native PS purified from porcine broncholveolar lavage.
The interfacial activity of PS/NP combinations has been assessed by captive
bubble surfactometry and surface balances. The results suggest that it is quite
feasible to design GNP-PS complexes with suitable features to being used in
real clinical settings.
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Yale University, New Haven, CT, USA.
pH (low) insertion peptide (pHLIP) is a helical peptide capable of inserting it-
self across a cell membrane at low pHs, but not at normal physiologic pH. It
possesses two carboxyl groups on aspartic acid residues in its transmembrane
region which are protonated at low pH, thereby increasing the peptide’s hydro-
phobicity and facilitating transmembrane insertion. As a result, pHLIP can be
used to specifically target acidic disease tissues, including solid tumors, in vivo.
Here, intravenously injected fluorescent-labeled pHLIP is shown to localize to
melanoma in two different genetically engineered mouse models. These mouse
models harbor melanocyte-specific conditional alleles for mutations commonly
present in melanoma. Upon activation of the mutations by topical 4-hydroxy-
tamoxifen administration, these mice develop tumors from endogenous mela-
nocytes, thereby closely recapitulating the development of tumors in
a natural environment (Dankort et al., Nature Genetics 41, 544-52 (2009);
Damsky et al., Cancer Cell 20, 741-54 (2011)). To date, this is the most realistic
tumor model in which pHLIP has been utilized, and our results demonstrate for
the first time that pHLIP is capable of localizing to cutaneous lesions. This
opens the possibility of utilizing pHLIP for the detection of melanoma and
other skin cancers. In addition, pHLIP is capable of translocating polar mole-
cules attached to its inserting end across cell membranes. Currently, we are tak-
ing advantage of this property in order to develop pHLIP-based therapies
against melanoma.
